We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -8.89% | 20.50 | 19.00 | 21.00 | 22.50 | 19.50 | 22.50 | 226,703 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 149k | -7.14M | -0.1078 | -1.86 | 14.9M |
RNS Number:4201O Celsis International PLC 07 August 2003 Celsis International plc Appointment of Seymour Pierce as Nominated Advisor and Broker Celsis announces the appointment of Seymour Pierce as the Company's stockbroker with immediate effect. Seymour Pierce has displayed strong commitment to the Celsis turnaround since initiating research coverage late last year. The Seymour Pierce Life Sciences team, supported by its in-depth research, has sought to actively build investment interest during a period which has coincided with robust Group trading and share price performance. Jay Le Coque, Chief Executive commented: "We have been impressed with Seymour Pierce's insight, depth of research and professionalism. We have also been delighted with their fresh approach in developing interest amongst institutional investors and look forward to a future supported by their counsel and support." Keith Harris, Chairman & Chief Executive, Seymour Pierce commented: "Our Life Sciences team headed by Dr Brett Pollard has developed a reputation for offering a hands on service backed by incisive research. "I am delighted with Celsis' decision to appoint us and we look forward to working with the board in the coming years." 7 August 2003 Enquiries: Celsis International plc Tel: 01638 600151 Jay Le Coque, Chief Executive Officer College Hill Tel: 020 7457 2020 Nicholas Nelson Seymour Pierce Tel: 020 7107 8000 Jonathan Wright This information is provided by RNS The company news service from the London Stock Exchange END APPKGGGRNVNGFZM
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions